Medtronic Plc (MDT): Gary Lee Ellis , EVP & Global Ops and IT of Medtronic Plc sold 35,495 shares on Jul 13, 2016. The Insider selling transaction was reported by the company on Jul 14, 2016 to the Securities and Exchange Commission. The shares were sold at $88.64 per share for a total value of $3,146,205.75 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 14, 2016, Shirley A Jackson (director) sold 2,104 shares at $88.64 per share price.On Jul 8, 2016, Carol A Surface (SVP, Chief HR Officer) sold 9,787 shares at $87.08 per share price.Also, On Jul 6, 2016, Bryan C Hanson (EVP, President, MITG) sold 15,272 shares at $87.11 per share price.On Jun 7, 2016, Richard Kuntz (SrVP & Chief Scien, Clin, Reg) sold 49,905 shares at $82.60 per share price.
Shares of Medtronic PLC (MDT) ended Wednesday, Jul 13, 2016 session in red amid volatile trading. The shares closed down -0.17 points or -0.19% at $88.75 with 55,34,308 shares getting traded. Post opening the session at $88.92, the shares hit an intraday low of $88.46 and an intraday high of $89.23 and the price vacillated in this range throughout the day. The company has a market cap of $123,782 M and the number of outstanding shares has been calculated to be 1,39,47,31,900 shares. The 52-week high of Medtronic PLC is $89.25 and the 52-week low is $55.54.
Company has been under the radar of several Street Analysts.Medtronic PLC is Initiated by Guggenheim to Neutral. The Rating was issued on Jun 9, 2016.Medtronic PLC is Reiterated by Needham to Buy and the brokerage firm has raised the Price Target to $ 93 from a previous price target of $90 .The Rating was issued on Jun 7, 2016.Medtronic PLC is Reiterated by Wedbush to Neutral and the brokerage firm has raised the Price Target to $ 82 from a previous price target of $79 .The Rating was issued on Jun 1, 2016.Medtronic PLC is Initiated by Sun Trust Rbsn Humphrey to Buy and the brokerage firm has set the Price Target at $93. The Rating was issued on Apr 25, 2016.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops manufactures and markets its medical devices and technologies to hospitals physicians clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group Minimally Invasive Technologies Group Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine Neuromodulation Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic Inc. is a subsidiary of the Company.